Krazati is a 2nd-line targeted therapy that fights G12C-positive non-small cell lung cancer. As Copy Supervisor on the DTC team, I helped lead a message exploration project that involved more than 30 interviews with patients, caretakers, healthcare providers, and one key opinion leader.

We tested and refined approximately 25 new consumer messages, simplifying complex subject matter into inspiring, understandable language for people facing an incredibly scary situation.

The resulting messages are now being used to refresh key patient materials, including the product brochure and patient website.